Sort   by:  
 Page size 
UnknownA 2-Dose AERAS-402 Regimen Boosts CD8+ Polyfunctionality in HIV-Negative, BCG-Vaccinated Recipients.
Not available
S-EPMC8231292 | biostudies-literature
UnknownDevelopment of a TB vaccine trial site in Africa and lessons from the Ebola experience.
Not available
S-EPMC7316575 | biostudies-literature
UnknownMesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis.
Not available
S-EPMC2819654 | biostudies-literature
UnknownSequence-based HLA-A, B, C, DP, DQ, and DR typing of 100 Luo infants from the Boro area of Nyanza Province, Kenya.
Not available
S-EPMC5519768 | biostudies-literature
UnknownPI3K/AKT signaling is essential for communication between tissue-infiltrating mast cells, macrophages, and epithelial cells in colitis-induced cancer.
Not available
S-EPMC3947836 | biostudies-literature
UnknownAdenovirally-Induced Polyfunctional T Cells Do Not Necessarily Recognize the Infected Target: Lessons from a Phase I Trial of the AERAS-402 Vaccine.
Not available
S-EPMC5141283 | biostudies-literature
UnknownThe TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial.
Not available
S-EPMC6123489 | biostudies-literature
UnknownA double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants.
Not available
S-EPMC6698638 | biostudies-literature
UnknownPhase 2b Controlled Trial of M72/AS01<sub>E</sub> Vaccine to Prevent Tuberculosis.
Not available
S-EPMC6151253 | biostudies-literature
Sort   by:  
 Page size